Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
28.08
-0.71 (-2.47%)
Sep 9, 2026, 4:00 PM EDT - Market closed
Apnimed Employees
Apnimed had 65 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
65
Change
n/a
Growth
n/a
Revenue / Employee
$1,848,462
Profits / Employee
-$489,631
Market Cap
1.56B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 65 | 0 | - |
| Dec 31, 2025 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 828 |
| Innoviva | 159 |
| Maze Therapeutics | 141 |
| Absci | 140 |
| Bicara Therapeutics | 103 |
| ArriVent BioPharma | 77 |
| Vor Biopharma | 76 |
APMD News
- 1 day ago - Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 days ago - Apnimed Quarterly report: Q2 2026 - Filings
- 2 days ago - Apnimed Earnings release: Q2 2026 - Filings
- 5 days ago - Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 16 days ago - Apnimed initiated with an Overweight at Cantor Fitzgerald - TheFly
- 16 days ago - Apnimed initiated with an Outperform at Evercore ISI - TheFly
- 16 days ago - Apnimed initiated with an Outperform at LifeSci Capital - TheFly